PRESCRIBING PATTERN OF ANTIHYPERTENSIVE INVOLVED IN HYPERTENSIVE PATIENTS IN ATERTIARY CARE TEACHING HOSPITAL
Journal: Indo American Journal of Pharmaceutical Sciences (IAJPS) (Vol.05, No. 05)Publication Date: 2018-05-20
Authors : Sriram A Dhanapal C.K; Junior Sundresh. N;
Page : 3638-3642
Keywords : Hypertension; ACE inhibitors; ARB blockers;
Abstract
Hypertension is one of the major global risk factor among the cardiovascular diseases leads to increase in morbidity, mortality rate as well as health burdens1 . In 2020 it has been estimated that 1.32 billion world populations will suffer from hypertension. As per current prevalence rate on hypertension in India is 18.52 and ranks at 67 among worldwide. WHO statistics reported that death rate among hypertensive patients in India was 1.79%. To determine the prescribing trends of antihypertensives involved in patients with hypertension. Out of 73 encounters, 43 (59%) males and 32(41%) females were observed and documented. Most patients with hypertension between the age group of 41 to 60 were 49(67.1%). The drug prescribing pattern involved with hypertension in this study was mostly single therapy (56.1%) when compared with combination therapy (43.9%). The most commonly used drug were amlodipine (4.1%) followed by clopidrogrel (8.2%), telmisartan (6.9%). The combination therapy was used frequently with Atorvastatin and fenofibrate (15%), Atenolol and amlodipine (11%), Telmisartan and hydrochlorothiazide (6.9%). The present study shows that ACE inhibitors and ARB blockers were frequently used in most of the prescriptions. Atorvastatin consumed more in all prescriptions followed by amlodipine and diuretics (furosemide). Key words: Hypertension, ACE inhibitors, ARB blockers
Other Latest Articles
- ASSESSMENT OF NUTRITIONAL KNOWLEDGE AND PRACTICES AMONG PREGNANT WOMEN
- ESTIMATION OF NAPROXEN AND ESOMEPRAZOLE SIMULTANEOUSLY IN TABLET DOSAGE FORM BY RPHPLC METHOD
- FORMULATION DEVELOPMENT AND EVALUATION OF DEFERASIROX DISPERSIBLE TABLETS
- DEVELOPMENT OF NEW RP-HPLC METHOD FOR SIMULTAENOUS ESTIMATION OF AMILORIDE AND HYDROCHLOROTHIAZIDE
- SOCIOECONOMIC AND DEMOGRAPHIC FACTORS LEADIN G TO NON-COMPLIANCE TOWARDS ANTI-TUBERCULOUS TREATMENT
Last modified: 2018-05-21 01:21:19